This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kalser MH and Ellenberg SS (1985) Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899–903
Klinkenbijl JH et al. (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230: 776–782
Neoptolemos JP et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200–1210
Abrams RA et al. (2006) RTOG 9704–Radiotherapy Quality Assurance (QA) Review and Survival. Int J Radiat Oncol Biol Phys 66 (Suppl 1): S22
Hsu CC et al. (2008) Benefit of adjuvant chemoradiation therapy for pancreatic adenocarcinoma: The Johns Hopkins Hospital–Mayo Clinic collaborative study of 1,045 patients [abstract #124]. In Proceedings of the ASCO Gastrointestinal Cancers Symposium: 2008 January 25–27; Orlando, FL
Picozzi VJ et al. (2003) Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 185: 476–480
Mehta VK et al. (2000) Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 48: 1483–1487
Acknowledgements
The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Feng, F., Ben-Josef, E. Radiation therapy improves survival in patients with pancreatic adenocarcinoma. Nat Rev Clin Oncol 5, 434–435 (2008). https://doi.org/10.1038/ncponc1176
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1176